Novartis has recalled a number of products that contain broken tablets. Most notable is Excedrin but the recall also includes NoDoz, Bufferin and Gas-X Prevention.
This certainly does not appear to be a big deal. Novartis issued these recalls as a precaution due to an internal product review and complaints that identified issues such as broken gelcaps, chipped tablets and inconsistent bottle packaging line clearance practices, where a potential for a tablet mix up could not be ruled out. Certainly, I bash drug companies enough on here. Novartis should be praised for taking this precaution.